ClinicalTrials.Veeva

Menu
G

Georgia Retina | Marietta - Clinical Trials Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Razuprotafib
Ranibizumab
APL-2
Pegcetacoplan
JNJ-81201887
AKB-9778

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm (PAVILION)

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Macular Edema (CI-DM...

Active, not recruiting
Diabetic Retinopathy
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Intravitreal Ranibizumab 0.5 mg Injection

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Active, not recruiting
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

Trial sponsors

A
E
Janssen (J&J Innovative Medicine) logo
Notal Vision logo
Roche logo
X

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems